SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-139021
Filing Date
2019-05-07
Accepted
2019-05-07 09:01:28
Documents
54
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d757900d10q.htm 10-Q 588192
2 EX-31.1 d757900dex311.htm EX-31.1 10377
3 EX-31.2 d757900dex312.htm EX-31.2 10265
4 EX-32.1 d757900dex321.htm EX-32.1 6007
  Complete submission text file 0001193125-19-139021.txt   2458382

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aqxp-20190331.xml EX-101.INS 361793
6 XBRL TAXONOMY EXTENSION SCHEMA aqxp-20190331.xsd EX-101.SCH 28873
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqxp-20190331_cal.xml EX-101.CAL 45046
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqxp-20190331_def.xml EX-101.DEF 61520
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqxp-20190331_lab.xml EX-101.LAB 234343
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqxp-20190331_pre.xml EX-101.PRE 163555
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 19801473
SIC: 2834 Pharmaceutical Preparations